SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,167,000 | +20.7% | 46,400 | 0.0% | 0.09% | -33.3% |
| Q3 2020 | $967,000 | -12.3% | 46,400 | 0.0% | 0.13% | -22.8% |
| Q2 2020 | $1,102,000 | +32.0% | 46,400 | 0.0% | 0.17% | +21.0% |
| Q1 2020 | $835,000 | -69.7% | 46,400 | -60.1% | 0.14% | -73.1% |
| Q4 2019 | $2,756,000 | -13.7% | 116,200 | 0.0% | 0.51% | -19.7% |
| Q3 2019 | $3,193,000 | -17.0% | 116,200 | 0.0% | 0.64% | -41.2% |
| Q2 2019 | $3,845,000 | +18.0% | 116,200 | +24.9% | 1.09% | -6.7% |
| Q1 2019 | $3,259,000 | +68.6% | 93,000 | +59.8% | 1.16% | +18.4% |
| Q4 2018 | $1,933,000 | – | 58,200 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |